Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/24 21:33 | 3/12/24 | JSPR | Health | BioPrd | Biological Products, (No Diag | Mahal Jeetinder Singh | CA | O | COO | 2 | S.d | -39 | 3.91 | 0 | -10 | 287 | D | |||||||||||||||
10/13/23 18:56 | 4/13/23 | JSPR | Health | BioPrd | Biological Products, (No Diag | Lis William | CA | D | 2 | S | -19 | 1.16 | 0 | -16 | 61 | D | ||||||||||||||||
4/14/23 16:19 | 4/14/23 | JSPR | Health | BioPrd | Biological Products, (No Diag | French Anna Louise | CA | D | 1 | S | -10 | 1.48 | 0 | -7 | 24 | D | ||||||||||||||||
4/14/23 16:19 | 4/13/23 | JSPR | Health | BioPrd | Biological Products, (No Diag | Emster Kurt Von | CA | D | 1 | S | -14 | 1.49 | 0 | -9 | 21 | D | ||||||||||||||||
1/26/23 17:49 | 1/25/23 | JSPR | Other | Other | American Depositary Receipts | Roche Holding Ltd | V8 | T | 1 | S | -142 | 1.89 | 0 | -75 | 4,550 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |